Cas:119516-33-5 3-[4-(diethylamino)phenyl]prop-2-enenitrile manufacturer & supplier

Chemical Name:3-[4-(diethylamino)phenyl]prop-2-enenitrile

CAS.NO:119516-33-5

Synonyms:3-[4-(diethylamino)phenyl]prop-2-enenitrile

Molecular Formula:C₁₃H₁₆N₂

Molecular Weight:200.28000

HS Code:

Physical and Chemical Properties:

Melting point:98-100ºC(lit.)

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:27.03000

Exact Mass:200.13100

LogP:3.06958

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 3-[4-(diethylamino)phenyl]prop-2-enenitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-[4-(diethylamino)phenyl]prop-2-enenitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-[4-(diethylamino)phenyl]prop-2-enenitrile Use and application,3-[4-(diethylamino)phenyl]prop-2-enenitrile technical grade,usp/ep/jp grade.

Related News: It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 3-[4-(diethylamino)phenyl]prop-2-enenitrile manufacturer An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 3-[4-(diethylamino)phenyl]prop-2-enenitrile supplier Saudi Arabia��s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters. 3-[4-(diethylamino)phenyl]prop-2-enenitrile vendor It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 3-[4-(diethylamino)phenyl]prop-2-enenitrile factory An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.